Medtronic PLC (MDT) Shares Sold by Central Bank & Trust Co.

Central Bank & Trust Co. reduced its holdings in shares of Medtronic PLC (NYSE:MDT) by 3.6% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 5,171 shares of the medical technology company’s stock after selling 192 shares during the quarter. Central Bank & Trust Co.’s holdings in Medtronic PLC were worth $459,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of MDT. Waldron LP bought a new position in shares of Medtronic PLC during the 1st quarter worth approximately $512,000. Leavell Investment Management Inc. boosted its stake in shares of Medtronic PLC by 10.5% during the 1st quarter. Leavell Investment Management Inc. now owns 5,641 shares of the medical technology company’s stock worth $454,000 after acquiring an additional 536 shares during the period. Valicenti Advisory Services Inc. boosted its stake in shares of Medtronic PLC by 4.2% during the 1st quarter. Valicenti Advisory Services Inc. now owns 11,656 shares of the medical technology company’s stock worth $939,000 after acquiring an additional 475 shares during the period. Schmidt P J Investment Management Inc. boosted its stake in shares of Medtronic PLC by 1.9% during the 1st quarter. Schmidt P J Investment Management Inc. now owns 20,942 shares of the medical technology company’s stock worth $1,687,000 after acquiring an additional 390 shares during the period. Finally, Meyer Handelman Co. boosted its stake in shares of Medtronic PLC by 1.9% during the 1st quarter. Meyer Handelman Co. now owns 316,386 shares of the medical technology company’s stock worth $25,487,000 after acquiring an additional 5,990 shares during the period. Institutional investors own 80.75% of the company’s stock.

Medtronic PLC (NYSE:MDT) traded up 0.39% during trading on Friday, hitting $82.12. The stock had a trading volume of 9,563,374 shares. The company has a 50-day moving average of $82.18 and a 200-day moving average of $83.65. The stock has a market capitalization of $111.24 billion, a P/E ratio of 27.64 and a beta of 1.03. Medtronic PLC has a 52 week low of $69.35 and a 52 week high of $89.72.

Medtronic PLC (NYSE:MDT) last issued its quarterly earnings data on Tuesday, August 22nd. The medical technology company reported $1.12 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.08 by $0.04. Medtronic PLC had a return on equity of 12.92% and a net margin of 13.75%. The company had revenue of $7.39 billion for the quarter, compared to the consensus estimate of $7.44 billion. During the same quarter last year, the business posted $1.03 earnings per share. The firm’s revenue was up 3.1% compared to the same quarter last year. On average, equities analysts expect that Medtronic PLC will post $4.77 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 20th. Investors of record on Friday, September 29th will be given a $0.46 dividend. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $1.84 dividend on an annualized basis and a dividend yield of 2.24%. Medtronic PLC’s dividend payout ratio (DPR) is presently 61.95%.

MDT has been the subject of several research analyst reports. CIBC reiterated a “buy” rating on shares of Medtronic PLC in a research note on Friday, May 26th. Needham & Company LLC reiterated a “buy” rating and set a $95.00 target price (up from $91.00) on shares of Medtronic PLC in a research note on Thursday, May 25th. Oppenheimer Holdings, Inc. reiterated a “buy” rating and set a $93.00 target price (up from $87.00) on shares of Medtronic PLC in a research note on Thursday, May 25th. UBS AG reiterated a “buy” rating and set a $95.00 target price (up from $94.00) on shares of Medtronic PLC in a research note on Tuesday, May 30th. Finally, BidaskClub downgraded Medtronic PLC from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 24th. Three investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and thirteen have given a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average target price of $88.78.

In related news, EVP Bryan C. Hanson sold 12,000 shares of the stock in a transaction on Monday, July 17th. The stock was sold at an average price of $88.57, for a total value of $1,062,840.00. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Richard H. Anderson acquired 5,600 shares of the stock in a transaction that occurred on Wednesday, June 21st. The stock was acquired at an average price of $88.90 per share, for a total transaction of $497,840.00. Following the transaction, the director now directly owns 71,910 shares of the company’s stock, valued at approximately $6,392,799. The disclosure for this purchase can be found here. Company insiders own 0.31% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Medtronic PLC (MDT) Shares Sold by Central Bank & Trust Co.” was posted by Chaffey Breeze and is owned by of Chaffey Breeze. If you are viewing this news story on another domain, it was stolen and republished in violation of US and international copyright laws. The correct version of this news story can be accessed at https://www.chaffeybreeze.com/2017/09/16/medtronic-plc-mdt-shares-sold-by-central-bank-trust-co.html.

Medtronic PLC Profile

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group.

Want to see what other hedge funds are holding MDT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medtronic PLC (NYSE:MDT).

Institutional Ownership by Quarter for Medtronic PLC (NYSE:MDT)

Receive News & Ratings for Medtronic PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic PLC and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply